CONDENSED CONSOLIDATED CASH FLOW STATEMENTS (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 24,594	$ 22,245
Adjustments to reconcile net income to net cash used for operating activities:
Depreciation and amortization	21,238	22,546
Share-based compensation	4,566	3,419
Pension funding less than pension expense	763	798
Loss on sale of business	562
Provision for inventory obsolescence	63	474
Income from equity method investment	(954)	(2,271)
Deferred income tax benefit	(2,248)
Tax benefit related to share-based compensation	(3,264)	(4,227)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:
Receivables	(6,490)	(9,785)
Inventories	(13,268)	(2,723)
Accounts payable	1,252	5,520
Accrued liabilities	(40,748)	(30,347)
Accrued taxes	(1,374)	(69,987)
Other assets	(2,417)	(5,606)
Other liabilities	(2,690)	(1,782)
Net cash used for operating activities	(20,415)	(71,726)
Cash flows from investing activities:
Capital expenditures	(10,356)	(6,437)
Cash used to acquire businesses, net of cash acquired	(4,700)	(9,475)
Proceeds (payments) from disposal of businesses	(956)	3,735
Proceeds from disposal of tangible assets	12	1,077
Net cash used for investing activities	(16,000)	(11,100)
Cash flows from financing activities:
Proceeds from exercise of stock options, net of withholding tax payments	(5,441)	1,551
Cash dividends paid	(2,172)	(76)
Debt issuance costs paid	(1,702)	(6,794)
Borrowings under credit arrangements		388,220
Payments under borrowing arrangements		(194,110)
Payments under share repurchase program		(31,250)
Tax benefit related to share-based compensation	3,264	4,227
Net cash provided by (used for) financing activities	(6,051)	161,768
Effect of foreign currency exchange rate changes on cash and cash equivalents	(1,259)	(4,631)
Increase (decrease) in cash and cash equivalents	(43,725)	74,311
Cash and cash equivalents, beginning of period	613,304	395,095
Cash and cash equivalents, end of period	$ 569,579	$ 469,406